XML 34 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments
 12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments
Note 10. Financial Instruments

Fair Value of Derivative Instruments:
Derivative instruments were recorded at fair value in the consolidated balance sheets as follows:
 As of December 31,
 20212020
Asset
Derivatives		Liability
Derivatives		Asset
Derivatives		Liability
Derivatives
 (in millions)
Derivatives designated as
accounting hedges:
Interest rate contracts$27 $17 $12 $340 
Net investment hedge derivative contracts (1)
117 45 114 129 
$144 $62 $126 $469 
Derivatives not designated as
   accounting hedges:
Currency exchange contracts$156 $40 $134 $119 
Commodity contracts387 137 205 128 
Equity method investment contracts(2)
— 3 — — 
$543 $180 $339 $247 
Total fair value$687 $242 $465 $716 

(1)Net investment hedge contracts consist of cross-currency interest rate swaps and forward contracts. We also designate some of our non-U.S. dollar denominated debt to hedge a portion of our net investments in our non-U.S. operations. This debt is not reflected in the table above, but is included in long-term debt discussed in Note 9, Debt and Borrowing Arrangements. Both net investment hedge derivative contracts and non-U.S. dollar denominated debt acting as net investment hedges are also disclosed in the Derivative Volume table and the Hedges of Net Investments in International Operations section appearing later in this footnote.
(2)Equity method investment contracts consist of the bifurcated embedded derivative option that was a component of the September 20, 2021 €300 million exchangeable bonds issuance. Refer to Note 9, Debt and Borrowing Arrangements.

Derivatives designated as accounting hedges above include cash flow and net investment hedge derivative contracts. Our currency exchange, commodity derivative and equity method investment contracts are economic hedges that are not designated as accounting hedges. We record derivative assets and liabilities on a gross basis on our consolidated balance sheets. The fair value of our asset derivatives is recorded within other current assets and other assets and the fair value of our liability derivatives is recorded within other current liabilities and other liabilities.

The fair values (asset/(liability)) of our derivative instruments were determined using:
 As of December 31, 2021
Total
Fair Value of Net
Asset/(Liability)		Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)		Significant
Other Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Currency exchange contracts$116 $— $116 $— 
Commodity contracts251 161 90 — 
Interest rate contracts10 10 
Net investment hedge contracts71 — 71 — 
Equity method investment contracts(3)— (3)— 
Total derivatives$445 $161 $284 $— 
 As of December 31, 2020
 Total
Fair Value of Net
Asset/(Liability)		Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)		Significant
Other Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Currency exchange contracts$15 $— $15 $— 
Commodity contracts77 46 31 — 
Interest rate contracts(328)— (328)— 
Net investment hedge contracts(15)— (15)— 
Total derivatives$(251)$46 $(297)$— 

Level 1 financial assets and liabilities consist of exchange-traded commodity futures and listed options. The fair value of these instruments is determined based on quoted market prices on commodity exchanges.

Level 2 financial assets and liabilities consist primarily of over-the-counter (“OTC”) currency exchange forwards, options and swaps; commodity forwards and options; net investment hedge contracts; and interest rate swaps. Our currency exchange contracts are valued using an income approach based on observable market forward rates less the contract rate multiplied by the notional amount. Commodity derivatives are valued using an income approach based on the observable market commodity index prices less the contract rate multiplied by the notional amount or based on pricing models that rely on market observable inputs such as commodity prices. Our bifurcated exchange options are valued, as derivative instrument liabilities, using the Black-Scholes option pricing model. This model requires assumptions related to the market price of the underlying note and associated credit spread combined with the share of price, expected dividend yield, and expected volatility of the JDE Peet’s shares over the life of the option. Our calculation of the fair value of interest rate swaps is derived from a discounted cash flow analysis based on the terms of the contract and the observable market interest rate curve. Our calculation of the fair value of financial instruments takes into consideration the risk of nonperformance, including counterparty credit risk. Our OTC derivative transactions are governed by International Swap Dealers Association agreements and other standard industry contracts. Under these agreements, we do not post nor require collateral from our counterparties. The majority of our derivative contracts do not have a legal right of set-off. We manage the credit risk in connection with these and all our derivatives by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure with each counterparty and monitoring the financial condition of our counterparties.
Derivative Volume:
The gross notional values of our derivative instruments were:
 Notional Amount
 As of December 31,
 20212020
 (in millions)
Currency exchange contracts:
Intercompany loans and forecasted interest payments
$1,891 $2,184 
Forecasted transactions
4,831 4,169 
Commodity contracts9,694 7,947 
Interest rate contracts1,850 3,500 
Net investment hedges:
Net investment hedge derivative contracts3,915 4,551 
Non-U.S. dollar debt designated as net investment hedges
Euro notes
3,622 3,744 
British pound sterling notes
356 360 
Swiss franc notes
811 1,175 
Canadian dollar notes
475 472 

Cash Flow Hedges:
Cash flow hedge activity, net of taxes, within accumulated other comprehensive earnings/(losses) included:
 For the Years Ended December 31,
 202120202019
 (in millions)
Accumulated (loss)/gain at beginning of period$(161)$(213)$(168)
Transfer of realized (gains)/losses in fair value to earnings(155)161 154 
Unrealized gain/(loss) in fair value168 (109)(199)
Accumulated (loss)/gain at end of period$(148)$(161)$(213)

After-tax gains/(losses) reclassified from accumulated other comprehensive earnings/(losses) into net earnings were:
 For the Years Ended December 31,
 202120202019
 (in millions)
Interest rate contracts$155 $(161)$(154)

Within interest and other expense, net, we recognized losses related to forward starting interest rate swaps of $79 million ($103 million pre-tax) in 2020 and a loss of $111 million in 2019.

After-tax gains/(losses) recognized in other comprehensive earnings/(losses) were:
 For the Years Ended December 31,
 202120202019
 (in millions)
Currency exchange contracts – forecasted transactions$— $(2)$3 
Interest rate contracts168 (107)(202)
Total$168 $(109)$(199)

Cash flow hedge ineffectiveness was immaterial for all periods presented.
We record pre-tax (i) gains or losses reclassified from accumulated other comprehensive earnings/(losses) into earnings, (ii) gains or losses on ineffectiveness and (iii) gains or losses on amounts excluded from effectiveness testing in interest and other expense, net for interest rate contracts.

Based on current market conditions, we would expect to transfer losses of $28 million (net of taxes) for interest rate cash flow hedges to earnings during the next 12 months.

Cash Flow Hedge Coverage:
As of December 31, 2021, our longest dated cash flow hedges were interest rate swaps that hedge forecasted interest rate payments over the next 4 years, 8 months.

Hedges of Net Investments in International Operations:

Net investment hedge (“NIH”) derivative contracts:
We enter into cross-currency interest rate swaps and forwards to hedge certain investments in our non-U.S. operations against movements in exchange rates. As of December 31, 2021, the aggregate notional value of these NIH derivative contracts was $3.9 billion and their impact on other comprehensive earnings and net earnings during the years presented below were as follows:
 For the Years Ended December 31,
 202120202019
 (in millions)
After-tax gain/(loss) on NIH contracts(1)
$63 $(221)$(6)

(1)Amounts recorded for unsettled and settled NIH derivative contracts are recorded in the cumulative translation adjustment within other comprehensive earnings. The cash flows from the settled contracts are reported within other investing activities in the consolidated statement of cash flows.
 For the Years Ended December 31,
 202120202019
 (in millions)
Amounts excluded from the assessment of
   hedge effectiveness(1)
$75 $117 $133 

(1)We elected to record changes in the fair value of amounts excluded from the assessment of effectiveness in net earnings within interest and other expense, net.

Non-U.S. dollar debt designated as net investment hedges:
After-tax gains/(losses) related to hedges of net investments in international operations in the form of euro, British pound sterling, Swiss franc and Canadian dollar-denominated debt were recorded within the cumulative translation adjustment section of other comprehensive income and were:
 For the Years Ended December 31,
 202120202019
 (in millions)
Euro notes$211 $(251)$60 
British pound sterling notes3 (8)(10)
Swiss franc notes29 (82)(19)
Canadian notes(3)(7)(17)
Economic Hedges:
Pre-tax gains/(losses) recorded in net earnings for economic hedges were:
 For the Years Ended December 31,Recognized
in Earnings
 202120202019
 (in millions) 
Currency exchange contracts:
   Intercompany loans and
      forecasted interest payments		$57 $(70)$100 Interest and other
expense, net
   Forecasted transactions80 41 17 Cost of sales
   Forecasted transactions(1)(4)(3)Interest and other
expense, net
   Forecasted transactions— (1)(8)Selling, general
and administrative
expenses
Commodity contracts385 4 67 Cost of sales
Equity method investment contracts2 — — Gain on equity method investment contracts
Total$523 $(30)$173